---
schema_version: "secwatch.filing_event.v1"
accession: "0001826466-24-000096"
form_type: "8-K"
ticker: "NIKA"
cik: "0001145604"
company_name: "NIKA PHARMACEUTICALS, INC"
filed_at: "2024-08-27T23:59:59+00:00"
generated_at: "2026-05-31T07:20:45.894351+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Nika cancels May 2024 acquisition of Nika Pharmaceuticals Ltd; auditor resigns

## Summary
- On Aug 18, 2024, board cancelled the acquisition of Nika Pharmaceuticals, Ltd. effective May 9, 2024; subsidiary returned to Savov on Aug 23.
- Nika no longer owns Nika Europe, Ltd. nor the factory/land assets acquired in May 2024.
- Independent auditor Fruci & Associates II, PLLC resigned on Aug 21, 2024; company seeking new auditor.
- Company states it will try to publish its 10-Q as early as possible.

## SEC filing metadata
- accession: 0001826466-24-000096
- form_type: 8-K
- ticker: NIKA
- cik: 0001145604
- company_name: NIKA PHARMACEUTICALS, INC
- filed_at: 2024-08-27T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.01, 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1145604/000182646624000096/0001826466-24-000096-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1145604/000182646624000096/form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001826466-24-000096
- JSON: https://secwatch.observer/filing/0001826466-24-000096.json
- Plain text: https://secwatch.observer/filing/0001826466-24-000096.txt

## Key facts
- M&A Transactions
  NIKA PHARMACEUTICALS, INC completed a disposition involving Dimitar Slavchev Savov (closed 2024-08-23).
  - Action: disposition
  - Counterparty: Dimitar Slavchev Savov
  - Closing: 2024-08-23
  source text: The procedure to return the 100% to Dimitar Slavchev Savov, who is an officer and director of Nika Pharmaceluticals, Inc. and general manager of Nika Pharmaceuticals, Ltd., was initiated on August 19, 2024 and was made effective on August 23, 2024, resulting in Nika Pharmaceuticals, Ltd. no longer being a wholly owned subsidiary of Nika Pharmaceuticals, Inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1145604/000182646624000096/0001826466-24-000096-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.